PUTHENPARAMPIL, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.336
AS - Asia 559
EU - Europa 551
SA - Sud America 72
AF - Africa 4
OC - Oceania 1
Totale 3.523
Nazione #
US - Stati Uniti d'America 2.325
SG - Singapore 324
IT - Italia 304
CN - Cina 162
BR - Brasile 64
DE - Germania 51
SE - Svezia 35
FI - Finlandia 33
HK - Hong Kong 33
GB - Regno Unito 31
RU - Federazione Russa 24
NL - Olanda 22
FR - Francia 20
VN - Vietnam 15
IN - India 12
UA - Ucraina 9
IE - Irlanda 7
CA - Canada 5
IR - Iran 5
CI - Costa d'Avorio 4
AT - Austria 3
CH - Svizzera 3
JP - Giappone 3
PL - Polonia 3
PR - Porto Rico 3
EC - Ecuador 2
ES - Italia 2
VE - Venezuela 2
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
JO - Giordania 1
KZ - Kazakistan 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
QA - Qatar 1
RO - Romania 1
TR - Turchia 1
UY - Uruguay 1
Totale 3.523
Città #
Fairfield 375
Woodbridge 210
Ashburn 206
Chandler 177
Singapore 156
Cambridge 145
Santa Clara 130
Houston 126
Seattle 113
Wilmington 111
Ann Arbor 100
Boardman 64
Padova 64
Beijing 36
San Diego 35
Hong Kong 33
Princeton 31
Milan 30
Medford 29
Rome 26
Des Moines 21
Helsinki 19
Roxbury 18
Los Angeles 16
Dong Ket 15
Norwalk 15
The Dalles 14
Jacksonville 13
London 12
Cagliari 10
Nanjing 10
Nuremberg 10
New York 9
Nanchang 8
Lappeenranta 7
Villafranca Padovana 7
Dublin 6
Grignasco 6
Guangzhou 6
Vicenza 6
Chicago 5
Hefei 5
Washington 5
Abidjan 4
Amsterdam 4
Bologna 4
Brendola 4
Falkenstein 4
Moscow 4
Ogden 4
Porto Alegre 4
Shenyang 4
São Paulo 4
Venice 4
Verona 4
Bari 3
Battaglia Terme 3
Borås 3
Chiaravalle 3
Genoa 3
Jiaxing 3
Juana Diaz 3
Kunming 3
Livorno 3
Mondolfo 3
Ottawa 3
Scandicci 3
Tehran 3
Turin 3
Alatri 2
Albese Con Cassano 2
Albignasego 2
Belo Horizonte 2
Bergheim 2
Boston 2
Brasília 2
Buffalo 2
Castelfidardo 2
Clifton 2
Fonte Nuova 2
Frankfurt am Main 2
Guarulhos 2
Hebei 2
Jinan 2
Kashan 2
Latina 2
Lauterbourg 2
Munich 2
Naples 2
Oliena 2
Quito 2
Ravenna 2
Reggio Nell'emilia 2
Revere 2
Rimini 2
Rovato 2
Rovigo 2
San Vitaliano 2
Strawczyn 2
Tianjin 2
Totale 2.592
Nome #
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study 195
BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset 147
Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset 140
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: A common, transient and clinically silent phenomenon 137
Cortical relapses in multiple sclerosis 136
Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy 131
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. 125
Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination 125
Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis 114
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 113
Hyperreflective Foci in the Retina of Active Relapse-Onset Multiple Sclerosis 112
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset 111
Cortical lesions and cognitive impairment in multiple sclerosis. 110
Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands 97
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset 92
PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East Italy 89
A new T2 lesion in a patient with the clinically isolated syndrome does not necessarily imply a conversion to multiple sclerosis 87
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis 86
Increased incidence of multiple sclerosis in the Veneto region, Italy. 85
Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis 83
Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies 78
NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis 77
D-KEFS ST failure identifies multiple sclerosis patients with worse objective and self-perceived physical and cognitive disability 77
Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patient 76
Multiple Sclerosis Incidence and Prevalence Trends in the Province of Padua, Northeast Italy, 1965-2018 72
Validation of SMAC: normative data in the Italian population 67
Association of Multiple Sclerosis with PM 2.5 levels. Further evidence from the highly polluted area of Padua Province, Italy 55
Posterior reversible encephalopathy syndrome: an atypical neurological manifestation of SARS-CoV-2 infection 49
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 45
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 44
null 42
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis 41
Hyper-Reflecting Foci in Multiple Sclerosis Retina Associate With Macrophage/Microglia-Derived Cytokines in Cerebrospinal Fluid 38
Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis 36
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis 35
Profili clinici nella Sclerosi Multipla: riserva cognitiva e compromissione motoria lungo il decorso della malattia. 35
Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration 32
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis 31
Sars-CoV2 infection in pregnant women with multiple sclerosis 28
Case Report: Para-infectious cranial nerve palsy after bacterial meningitis 27
T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis 27
Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis 24
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review 23
High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis 22
Neurodegeneration in the retina of motoneuron diseases: a longitudinal study in amyotrophic lateral sclerosis and Kennedy’s disease 21
Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis 20
Sexual Dysfunction in Multiple Sclerosis: The Role of Executive Function 20
Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS 20
Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders? 19
Case report: Breaking CNS immuno-privilege: TNFα-inhibitor triggers aseptic meningitis in a patient with rheumatoid arthritis 18
Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors 18
The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers 17
Blood biomarkers for Alzheimer’s disease with the Lumipulse automated platform: Age-effect and clinical value interpretation 15
A comparison of natalizumab's effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients. 15
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 10
Neuropsychological awareness in pediatrics (NAP): Proposal of a new cognitive self-report questionnaire for pediatric multiple sclerosis patients 8
Hyper-reflective foci changes in RRMS under natalizumab therapy 8
A comparison of natalizumab’s effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients 7
Encephalopathy as unique manifestation of Sjogren's syndrome: Expanding the spectrum of steroid-responsive encephalopathy 6
The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis 5
Relapsing tumefactive demyelination lesions: A unique, distinct inflammatory brain pathology 4
Characterization of children with early onset pediatric multiple sclerosis 3
Totale 3.630
Categoria #
all - tutte 17.656
article - articoli 17.326
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 0 0 0 0 0 52 39 26
2020/2021469 16 39 23 28 8 10 12 37 29 132 52 83
2021/2022428 13 14 45 33 31 53 20 46 17 30 33 93
2022/2023418 54 39 19 45 55 55 13 33 61 13 20 11
2023/2024398 12 43 47 37 36 48 31 24 14 24 39 43
2024/20251.069 19 104 63 87 241 45 98 183 134 95 0 0
Totale 3.630